Moneycontrol
HomeNewsBusinessEconomyCOVID-19 impact | Group health insurance premiums may rise 10-15%
Trending Topics

COVID-19 impact | Group health insurance premiums may rise 10-15%

Coronavirus led cost increase has forced insurers to also review their annual pricing for group health products.

May 08, 2020 / 14:43 IST
Story continues below Advertisement

The coronavirus (COVID-19) outbreak has led to a spike in healthcare costs in the country. Medical bills are going through the roof for patients while hospitals blame it on additional costs incurred to check infection. Amidst all this, the insurance premiums for group health covers may also go to 10-15 percent in the next six to seven months with rising claims.

“There are group insurance policyholders incurring higher charges for COVID-19 treatment. But even for regular procedures, individuals are choosing high-end hospitals increasing the claim amount. This is adding to total costs,” said the head of underwriting at a mid-size private insurer.

Story continues below Advertisement

Group health covers are taken by corporates for their employees. The premium is dependent on the number of employees, profession and location of the facility. It can range between Rs 1,500 to 5,000. The policies are renewed on an annual basis.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show